|
![[Under Construction]](images/undercon.gif)
| |
Publications form the Unit include:
| Publications |
| 2001 |
Validation of the S(AD)2 classification of
diabetic foot ulcers
Treece KA, Jeffcoate WJ, Macfarlane RM, Pound N
Diabetologia
44:1091 Suppl 1 Aug 2001 |
| |
Is it better if we show a fall, or a rise, in the rate of major
amputation?
Pound N, Jeffcoate WJ, Macfarlane RM, Treece KA & Game F
Diabetologia 44:1072 Suppl 1 Aug 2001 |
| |
Validation of
the S(AD)SAD classification of diabetic foot ulcers
Jeffcoate WJ, Treece KA, Macfarlane RM, Pound N
Diabetes 50: A227-A228
Suppl 2 Jun 2001 |
| |
A computerised
register for use in the foot clinic
Pound N, Treece KA, Jeffcoate WJ,
Macfarlane RM
Diabetes 50: A487-A487 Suppl 2 Jun 2001 |
| 2002 |
Mortality in the Charcot Foot
Compared with Diabetics with Uncomplicated Neuropathic Ulceration
Diabetologia 45:1046 Suppl 2 Aug 2002 |
| 2003 |
Outcome in diabetic foot ulcers with and without methicillin resistant
Staphylococcus aureus (MRSA)
Game FL, Boswell T, Soar C, Houghton E, Treece K, Pound N,
Jeffcoate WJ
Diabetic Medicine Suppl 20 2:30, April 2003 |
| |
Diabetic foot ulcers
Jeffcoate WJ, Harding
KG.
Lancet.
361:1545-51. |
| 2004 |
|
| |
Morbidity and Mortality in Patients with Diabetic Neuropathic
Osteoarthropathy (Charcot Foot)
Gazis A, Pound N,
Macfarlane R, Treece K, Game F and Jeffcoate W
Diabetic Medicine 2004 (in
press) |
| |
Validation of a
new system of foot ulcer classification in diabetes Mellitus.
Treece KA, Macfarlane RM, Pound N, Game FL,
Jeffcoate WJ.
Diabetic Medicine
21:
987-991 |
| |
Guidelines for
research into the management of diabetic foot ulcers.
Jeffcoate WJ, Price PE.
Diabetes & Metabolism Research Reviews (Review) |
| |
Controversies in diagnosing and managing osteomyelitis in diabetes.
Jeffcoate WJ, Lipsky BA.
Clinical Infectious Disease 39 (Suppl 2): S115-122. |
| |
Wound healing and
treatments for people with diabetic foot ulcers.
Jeffcoate W,
Price PE, Harding KG.
Diabetes Metabolism Research Reviews
20:
Suppl 1:S78-89 |
| |
Vascular
calcification and osteolysis in diabetic neuropathic osteoarthropathy:
is RANK-L the missing link ?
Jeffcoate W.
Diabetologia Sep 47(9): 1488-92 |
| |
Hormonal, metabolic
and mitochondrial changes in critical illness: a trigger for organ
failure ?
Singer M, De
Santis V, Vitale D, Jeffcoate WJ.
Lancet 364: 545-548. |
| |
Amputation as a
marker of the quality of foot care in diabetes.
Jeffcoate W, Van
Houtum WH.
Diabetologia. 2004 Dec;47(12):2051-8. Review. |
| |
Unexplained inflammation and deformity of the foot.
Jeffcoate WJ, Game FL, Connor H.
Hospital Medicine 65: 498-499. |
| |
Incidence of
amputation is a poor measure of quality of care in the diabetic foot.
Jeffcoate WJ.
The Diabetic Foot 7: 70-76. |
| |
The structure of foot
ulcer trials: choice of outcome measures.
Jeffcoate W.
The Diabetic
Foot
7:
8-14 |
| |
Validation of a
system of foot ulcer classification in diabetes mellitus.
Treece KA,
Macfarlane RM, Pound N, Game FL, Jeffcoate WJ.
Diabet Med
Sep; 21(9): 987-91. |
| |
Erythromelia,
or Mitchells’ Syndrome – new names for unexplained signs of
inflammation in distal symmetrical neuropathy in diabetes.
Jeffcoate
WJ, Idris I, Game FL.
Diabet Med. 2004 Dec;21(12):1334-8 |
| |
Reducing the menace of gangrene and amputation in diabetes.
Jeffcoate W, Game F.
Diabetographia Med Review 6:5-7 (Servier) |
| |
MRSA
and osteomyelitis of the foot in diabetes.
Game F, Jeffcoate W.
Diabetic Medicine
21
(Suppl 4): 16-19. |
| |
The proper management
of diabetic foot ulcers: time for a paradigm shift
Jeffcoate WJ.
Diabetic Medicine 21: 809 (editorial). |
| |
Off-loading in trials
in neuropathic diabetic foot ulceration: no, it's not time for a
paradigm shift
Jeffcoate WJ,
Game FL, Price PE.
Diabetes Care 27: 635-6 (letter). |
| |
The definition of Charcot foot.
Jeffcoate W.
Diabetic Foot 7: 178-82. |
| |
Le
Pied de Charcot
Jeffcoate WJ, Kong M-F, Hartemann-Heurtier
A
In Les complications artérielles du diabète,
Kieffer E, Grimaldi.
A, eds. Paris:
AERCV, pp 135-40. |
| 2005 |
|
| |
Heel ulcers don’t heal in diabetes. Or do they ?
Chipchase SY, Treece KA, Pound N, Game FL, Jeffcoate WJ.
Diabetic Medicine Sep 22(9) 1258-62 |
| |
Does close glycaemic control promote healing in diabetic foot ulcers ?
Report of a feasibility study.
Idris I,
Game F, Jeffcoate W.
Diabetic Medicine Aug 22(8) 1060-3 |
| |
The incidence of amputation in
diabetes.
Jeffcoate
WJ
Acta Chir Belg. 2005 Apr;105(2):140-4. Review.
|
| |
Footing the
bill: World Diabetes Day.
Jeffcoate W, Bakker K.
Lancet 365: 1527
(Commentary). |
| |
Extending the scientific base of diabetic foot care.
Jeffcoate W.
The
Diabetic Foot 2005 (editorial comment) |
| |
Ulcer-free survival
following management of foot ulcers in diabetes.
Pound N, Treece K, Game F, Jeffcoate W.
Diabetic Medicine (in press) |
| |
The role of
pro-inflammatory cytokines in the cause of neuropathic osteoarthopathy
(acute Charcot foot) in diabetes.
Jeffcoate WJ,
Game F, Cavanagh PR.
Lancet
2005 (in press) |
| |
Infection du pied
diabétique.
Jeffcoate W, Game F,
Hartemann-Heurtier A.
In Journées
de Diabétologie Hôtel-Dieu.
Paris: Médecine-Sciences, Flammarion,
pp 131-41. |
| |
Abnormalities of vasomotor
regulation in the pathogenesis of the acute Charcot foot of diabetes
mellitus.
Jeffcoate WJ.
Int J Lower Extrem Wounds
4: 133-37. |
| |
Theories
concerning the pathogenesis of the acute Charcot foot suggest future
therapy.
Jeffcoate WJ.
Curr Diab Reports
5: 430-5. |
| |
Putting feet first in diabetes.
Anonymous (Jeffcoate WJ, James A)
Lancet
366: 1674 (Editorial) |
| |
US/European
drive to pool efforts to eliminate the burden of type 1 diabetes.
Jeffcoate W.
Lancet 367: 795-7
(Commentary). |
| |
Footing the
bill: World Diabetes Day.
Jeffcoate W, Bakker K.
Lancet 365: 1527 (Commentary). |
| 2006 |
|
| |
Education in the management of the
foot in diabetes.
Radford K, Chipchase S, Jeffcoate W.
In The Foot in Diabetes 4th edn (Boulton AJM,
Cavanagh PR, Rayman G, eds).
London: John Wiley & Sons Ltd. |
| |
The description, classification and
registration of diabetic foot lesions.
Jeffcoate W, Game F.
In The Foot in Diabetes 4th edn (Boulton AJM,
Cavanagh PR, Rayman G, eds).
London: John Wiley & Sons Ltd. |
| |
Diabetes, established renal failure
and the risk to the lower limb.
Hinchliffe RJ, Jeffcoate WJ, Game FL.
Pract Diab Int
23: 1-5. |
| |
Should annual measurement of the
ankle-brachial index be routine practice in diabetes care ?
Nature Clin Pract
2:3. (Commentary) |
| |
Changing incidence of major
amputation for diabetes in Novi Sad, Serbia and Montenegro between 1994
and 2004.
Tesic DS, Pantelinac P,
Avramov S, Vukobratov V,
Pasternak J, Jeffcoate WJ.
Diab Care 29: 741-2. |
| |
Probing the
validity of the probe to bone test in the diagnosis of osteomyelitis of
the foot in diabetes.
Shone A, Burnside J,
Chipchase S, Game F, Jeffcoate W.
Diab Care 29: 945. |
| |
Evidence
that the content of foot care education is influenced by differing
professional opinion
Kneepkens H, Lincoln NB, Radford K, Jeffcoate WJ,
von
Fragstein M , Game FL.
Diabetic Foot
9: 14-20. |
| |
The effect of haemodialysis on
transcutaneous oxygen tension in patients with diabetes.
Hinchliffe R, Kirk B,
Roe S, Jeffcoate W, Game F.
Nephrol Dial Transplant;
21: 1981-3. |
| |
Assessing the outcome of the
management of diabetic foot ulcers using ulcer-related and
person-related measures.
Jeffcoate WJ, Chipchase SY, Game FL
Diab Care 29: 1784-7 |
| |
Temporal association between the
incidence of foot ulceration and the start of dialysis in diabetes
mellitus.
Jeffcoate WJ,
Chipchase SY, Hubbard R, Burden RP, Game FL.
Nephrol Dial Transplant
Jul 28; [Epub ahead of print] |
| |
The absence of
evidence base for the use of antibiotics in diabetic foot ulcer: what
are we going to do about it ?
Jeffcoate W.
Diabet Med (Editorial) 23: 339-340 (Editorial) |
| |
Acute neuropathic joint disease: a
medical emergency ?
Jeffcoate WJ, Game FL,
Armstrong DG, Cavanagh PR.
Diab Care 29: 951-2 |
| |
Erythromelalgia.
Jeffcoate W.
Commissioned entry in Encyclopedic References of Molecular
Mechanisms of
Disease (Lang F, ed) Heidelberg: Springer. |
| |
World Diabetes
Day 2006.
Jeffcoate W, Williams R.
Lancet 367: (Commentary) |
| |
US/European
drive to pool efforts to eliminate the burden of type 1 diabetes
Jeffcoate W.
Lancet 367: 795-7 (Commentary). |
| |
Should eponyms be actively detached from diseases ?
Jeffcoate W.
Lancet 367:
1296-7 (Commentary) |
| |
Mismanagement as a prelude to privatisation of the UK NHS.
Jeffcoate
W.
Lancet
368: 98-100. |
| |
Temporal
association between the incidence of foot ulceration and the start of
dialysis in diabetes mellitus.
Jeffcoate WJ, Chipchase SY, Hubbard R, Burden RP, Game FL.
Nephrol Dial Transplant 21: 3207-10. |
| 2007 |
|
| |
Long-awaited formula for the improvement of foot care in diabetes.
Stuart L, Jeffcoate W.
Pract Diab Int 2007; 24:
122. (Leading article) |
| |
Education for the prevention of foot ulcers: Views of those with
neuropathy.
Burnside J, Wells W, Smith M, Game F, Jeffcoate W, Radford K.
The Diabetic Foot
10: 17-23. |
| |
Rate of healing of neuropathic ulcers of the foot in diabetes and its
relationship to ulcer duration and ulcer area.
Ince P, Game FL, Jeffcoate WJ.
Diab Care
30: 660-3. |
| |
Validation of a new measure of protective foot care behaviour:the
Nottingham Assessment of Functional Footcare (NAFF).
Lincoln NB, Ince P, Smith M, Jeffcoate
WJ, Radford.KA.
Pract Diabet Int 24:207-211. |
| |
The association baseline characteristics and the outcome of foot lesions
in a UK population with diabetes.
Ince P, Kendrick D, Game F, Jeffcoate W.
Diabet Med
24(9):977-81.
|
| 2008 |
|
| |
The causes of the Charcot syndrome.
Jeffcoate W.
Clinics in Podiatric Medicine and Surgery
25: 29-42. |
| |
Screening to identify individuals at high risk of developing diabetic
foot ulcers.
Nat Clin Pract Endocrinol Metab Mar
4; [Epub ahead of print] |
| |
One
small step for diabetic podopathy.
Jeffcoate WJ.
Diabetologia
51:
214-5. (Commentary) |
| |
Use
of the SINBAD classification system and score in comparing outcome of
foot ulcer management in three continents.
Ince P, Abbas Z, Lutale J, Basir A,
Mansoor Ali S, Chohan F, Morbach S,
Mollenberg J, Game F, Jeffcoate W.
Diab Care Feb 25; [Epub ahead of print] |
| |
Primarily non-surgical management of osteomyelitis of the foot in
diabetes.
Game FL, Jeffcoate WJ.
Diabetologia Apr 3; [Epub ahead of print] |
| |
Comparison of four systems of classification of diabetic foot ulcers in
Tanzania.
Abbas ZG, Lutale JK, Game F,
Jeffcoate W.
Diabet Med
25:
134-7. |
| |
|
| |
|
| |
in
press: |
| |
A systematic review of the effectiveness of interventions to enhance the
healing of chronic ulcers of the foot in diabetes.
Hinchliffe R, Valk GD, Apelqvist J, Armstrong DG, Bakker K, Game Fl,
Hartemann-Heurtier A, Löndahl M, Price PE, van Houtum W, Jeffcoate WJ.
Diabetes Metab Res Rev |
| |
Diabetic Foot Osteomyelitis: a Progress Report on Diagnosis and a
Systematic Review of Treatment.
Berendt AR, Peters EJG, Bakker K, Embil JM, Eneroth M, Hinchliffe RJ,
Jeffcoate
WJ, Lipsky BA, Senneville E, Teh J, Valk GD.
Diabetes Metab Res Rev |
| |
Charcot’s disease: neuropathic osteoarthropathy.
Diabetes Metab Res Rev Epub
ahead of print, April 7th |
| |
New theories on the cause of the Charcot foot of diabetes.
In (R Frykberg ed). |
| |
Erythromelalgia.
Jeffcoate W.
Commissioned entry in Encyclopedic
References of Molecular Mechanisms of Disease (Lang F, ed)
Heidelberg: Springer. |
| |
Does it
need two kicks to re-start a process which is stalled ?
Jeffcoate WJ.
Excerpta Medica |
| |
|
| |
submitted |
| |
Education for secondary prevention of foot ulcers in people with
diabetes: an observer-blind, randomised controlled trial.
Lincoln NB, Radford KA, Game F, Jeffcoate WJ. Diabetologia |
| |
|
|
